Why is Fredun Pharmaceuticals Ltd ?
- The company has declared positive results for the last 10 consecutive quarters
- OPERATING CF(Y) Highest at Rs 16.44 Cr
- ROCE(HY) Highest at 20.50%
- NET SALES(Q) Highest at Rs 267.63 cr
- The technical trend has improved from Mildly Bullish on 19-Nov-26
- Multiple factors for the stock are Bullish like MACD, Bollinger Band, KST and DOW
- Along with generating 161.15% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
How much should you buy?
- Overall Portfolio exposure to Fredun Pharma should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Fredun Pharma for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at Rs 16.44 Cr
Highest at 20.50%
Highest at Rs 267.63 cr
Highest at 4.82 times
Highest at Rs 42.35 cr.
Highest at Rs 18.57 cr.
Lowest at 0.74 times
Highest at 8.90 times
Highest at Rs 29.65 cr.
At Rs 31.89 cr has Grown at 28.54%
Here's what is working for Fredun Pharma
Net Sales (Rs Cr)
PBT less Other Income (Rs Cr)
PAT (Rs Cr)
Net Sales (Rs Cr)
Operating Profit to Interest
Operating Profit (Rs Cr)
PAT (Rs Cr)
Operating Cash Flows (Rs Cr)
PBT less Other Income (Rs Cr)
Debt-Equity Ratio
Debtors Turnover Ratio
Here's what is not working for Fredun Pharma
Interest Paid (Rs cr)